S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

ASLAN Pharmaceuticals (ASLN) Earnings Date, Estimates & Call Transcripts

$0.71
-0.17 (-19.23%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ASLN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASLN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ASLAN Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.75)($0.75)($0.75)
Q2 20241($0.50)($0.50)($0.50)
Q3 20241($0.50)($0.50)($0.50)
Q4 20241($0.50)($0.50)($0.50)
FY 20244($2.25)($2.25)($2.25)

ASLN Earnings Date and Information

ASLAN Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 22nd, 2024 based off prior year's report dates.

ASLAN Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/22/2024
Estimated)
------- 
10/27/2023Q3 2023($0.85)($0.56)+$0.29($0.56)--
8/11/2023Q2 2023($0.80)($0.11)+$0.69($0.11)-$12.00 million
4/28/2023Q1 2023($0.80)($1.29)($0.49)($1.29)--
3/24/2023Q4 2022($0.95)($1.04)($0.09)($1.04)--
10/28/2022Q3 2022($1.00)($0.80)+$0.20($0.16)--
8/12/2022Q2 2022($1.00)($0.95)+$0.05($0.19)--
8/12/2022Q2 2022($1.00)($0.95)+$0.05($0.19)--
4/27/2022Q1 2022($0.85)($0.95)($0.10)($0.19)--
3/25/2022Q4 2021($0.75)($0.80)($0.05)($0.16)--
10/25/2021Q3 2021($0.65)($0.60)+$0.05($0.12)--
8/6/2021Q2 2021($0.55)($0.40)+$0.15($0.08)--
5/11/2021Q1 2021($0.55)($0.65)($0.10)($0.13)--
4/21/2021Q4 2020($0.50)($0.75)($0.25)($0.15)--












ASLAN Pharmaceuticals Earnings - Frequently Asked Questions

When is ASLAN Pharmaceuticals's earnings date?

ASLAN Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 22nd, 2024 based off last year's report dates. Learn more on ASLN's earnings history.

How much profit does ASLAN Pharmaceuticals generate each year?

ASLAN Pharmaceuticals (NASDAQ:ASLN) has a recorded net income of -$51.38 million. ASLN has generated -$3.00 earnings per share over the last four quarters.

What is ASLAN Pharmaceuticals's EPS forecast for next year?

ASLAN Pharmaceuticals's earnings are expected to decrease from ($2.56) per share to ($3.25) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ASLN) was last updated on 3/1/2024 by MarketBeat.com Staff